NEO-FLUCORT CREAM

Main information

  • Trade name:
  • VR NEO-FLUCORT CREAM TOPICAL ANTIBIOTIC ANTI-INFLAMMATORY CREAM
  • Available from:
  • VR
  • Pharmaceutical form:
  • TOPICAL CREAM, OINTMENT, PASTE, GEL, LOTION
  • Units in package:
  • 75g
  • Class:
  • Veterinary Medicine
  • Medicine domain:
  • Animals
  • Medicine type:
  • Allopathic drug
  • Manufactured by:
  • JUROX

Documents

Localization

  • Available in:
  • VR NEO-FLUCORT CREAM TOPICAL ANTIBIOTIC ANTI-INFLAMMATORY CREAM
    Australia
  • Language:
  • English

Therapeutic information

  • Therapeutic group:
  • CAT | DOG | HORSE | BITCH | CASTRATE | CAT - QUEEN | CAT - TOM | COLT | DONKEY | ENDURANCE HORSE | FILLY | FOAL | GELDING | HIGH
  • Therapeutic area:
  • antibiotic,anti-inflammat
  • Therapeutic indications:
  • ANTIBIOTIC - ANTI-INFECTIVE | ABRASIONS | ABSCESSES | AIRSACCULITIS | ANTISEPTIC | AVIAN MYCOPLASMAS | BLACKHEAD | BODY ODOURS | BOWED TENDONS | BROAD SPECTRUM | BURNS | COCCIDIOSIS | COLIFORM COMPLEX | CONJUNCTIVITIS | COWPOX | CRACKS | CRUSTS | DANDRUFF | DERMATOLOGICAL DISORDERS | DERMATOSIS | DRY SKIN | DYSENTERY | ECZEMA | ENDOMETRITIS | ENTERIC DISEASES | ENZOOTIC PNEUMONIA | FEED EFFICIENCY | FUNGAL INFECTIONS | GIRTH GALLS | INFECTIONS | INFLAMMED PADS | ITCHING | KERATOLYTIC | LACERATIONS | MASTITIS | MYCOPLASMAS | ODOURS | OPEN WOUNDS | OTITIS | PRURITIS | QUEENSLAND ITCH | RESPIRATORY DISEASE | SADDLE RASH | SALMONELLOSIS | SCABS | SCALY SKIN | SHEATH ROT | SKIN IRRITATIONS | SORES | SWINE DYSENTERY | TEAT CRACKING | TEAT INFECTIONS | TOPICAL INFECTIONS | UDDER SORES | WEIGHT GAIN | WIRE CUTS | WOUNDS
  • Product summary:
  • Relief of pruritis and inflammation associated with superficial acute and chronic dermatoses in dogs, cats and horses.Not to be used in food producing animals. For external use only.

Other information

Status

  • Source:
  • Australian Pesticides and Veterinary Medicines Authority (APVMA)
  • Authorization status:
  • Registered but not available
  • Authorization number:
  • 36067//01
  • Authorization date:
  • 28-05-1996
  • Last update:
  • 15-06-2017

Patient Information leaflet: composition, indications, side effects, dosage, interactions, adverse reactions, pregnancy, lactation

OZ

:::Dm

me

.1

~;!J

"--

PRESCRIPTION ANIMAL REMEDY

KEEP OUT OF REACH OF CHILDREN

FOR ANIMAL TREATMENT ONLY

..

NEO-FLUCORT CREAM

TOPICAL

ANTIBIOTIC

ANTI-INFLAMMATORY

CREAM

ACTlVE CONSTITUENTS:

0.25mg/g

FLUMETHASONE

5.0mg/g

NEOMYCIN SULFATE

)

75 9 NET

INDICATIONS:

NEO-FLUCORT CREAM is

indicated

In the relief

pruntis

inflammation

associated with superficial

acute

chronic

dermatoses in

dogs,

cats

horses

DIRECTIONS FOR USE:

Nollo

be

used on tood producing animals.

For external

use only.

Apply

to the affected area as directed.

DISPOSE of

container

wrapping

with

paper

and putting in

garbage.

STORE BELOW 25°C

(Air

Conditioning).

404415 NRA 36067/01

V'llV'!:J1snV'

'8Z~Z

'MSN!:J31V'M!:J3t\lIS

!:J3>tlOH

'31'ilS3

H8nOlS

liNn

xfUnf

Signat

,

.....

XfHnr

OZ

:::Dm

.L3N

6

SL

me

.'

3l:;!J

:::D

"'-

31\1':nns

NI:J}.,~03N

6/6UJO'S

3NOSV'H13~nl.:J

5/6wSZ'O :SlN3n1l1SNO:J

31\118\1'

WV3H:>

AI::IOJ.VWWV':lNI-IJ.NV

:>1J.OI81J.NV

'V:>ldOJ.

1N"3i::1~

!i::IO~nl:l-03N

1111

A.

1NO

J.N3WJ.

Y31::U

1YWINY

YO::l

N3Y01IH:>

::10

H:>Y3Y

::10

d33)1

A.03W3Y

1YWINY

NOlldIY:>S3Yd

SAMPLE

20

-

NEO-FLUCORT

CREAM

75 9

NET

INDICATIONS: NEO-FLUCORT CREAM is indicated in the relief

prurilis and

inflammation associated with superficial

acute and chronic dermatoses

dogs.

cats and horses.

DIRECTIONS FOR USE: Not to be used on food producing animals.

For external

use only.

Apply to the affected area as directed.

DISPOSE of container by wrapping with paper and placinq

garbage.

STORE below 2S"C (Air Conditioning)

I.

urox

Ply Ltd.

UNIT 22, SLOUGH ESTATE. HOLKER ST..

SILVERWATER, NSW. 2128.

AUSTRALIA

40442S NRA

36067101

PRESCRIPTION ANIMAL REMEDY

KEEP OUT OF REACH OF CHILDREN

FOR ANIMAL TREATMENT ONLY

ml1

NEO-FLUCORT·CREAM

TOPICAL

ANTI

BIOTIC

ANTI-IN

FLAMMATORY CREAM

ACTIVE CONSTITUENTS:

02Smg/g

FlUMETHASONE

SOmg/g

NEOMYCIN SULFATE

.urox

..

75 9 NET

Signatur

N.R.A.

APPROVED

ABEL

cf"

Date:

~~a...L..-LJ::+~

.r

200%

SIZE

PRESCRIPTION

ANIMAL

REMEDY

KEEP OUTOF

REACH

OFCHILDREN

FOR ANIMAL

TREATMENT

ONLY

mil

NEO-FLUCORT CREAM

TOPICAL ANTIBIOTIC ANTI-INFLAMMATORY CREAM

ACTIVE CONSTITUENTS;

O.25mg/g FLUMETHASONE

5.0mg/g NEOMYCIN SULFATE

15 9

NET

INDICATIONS:

NEO·FLUCORT CREAM is indicated in the relief of pruritis and inflammation

associated with superficial

acute and chronic dermatoses

in dogs.

cats and horses.

DIRECTIONS FOR USE:

to be

used

food

producing

animals.

For external

use only.

Apply to the affected area as directed.

DISPOSE of container

wrapping with

paper

and placing in garbage.

STORE below 25°C (Air Conditioning)

jUrOX

Pty Ltd.

UNIT 22, SLOUGH ESTATE. HOLKER ST..

SILVERWATER,

2128.

AUSTRALIA

404420 NRA 36067/01

Date:

;"'::;=--I-'--;;;~---71H--

18-10-2018

Unauthorized "Surfaz-SN Triple Action Cream" seized from Mississauga store may pose serious health risks

Unauthorized "Surfaz-SN Triple Action Cream" seized from Mississauga store may pose serious health risks

Health Canada seized “Surfaz-SN Triple Action Cream”—an unauthorized skin cream promoted for antifungal, antibacterial and anti-inflammatory use—because it is labelled to contain prescription drugs (betamethasone dipropionate and neomycin sulphate). The product was seized from Kaf African Caribbean Market (2642 Liruma Road, Unit 2A) in Mississauga, Ontario.

Health Canada

2-7-2018

Fagron Sterile Services Issues Voluntary Nationwide Recall of Neostigmine Methylsulfate 1mg/mL, 5mg per 5mL and Neostigmine Methylsulfate 1mg/mL, 3mg per 3mL, in a 5mL syringe Due to Mislabeling

Fagron Sterile Services Issues Voluntary Nationwide Recall of Neostigmine Methylsulfate 1mg/mL, 5mg per 5mL and Neostigmine Methylsulfate 1mg/mL, 3mg per 3mL, in a 5mL syringe Due to Mislabeling

Fagron Sterile Services is voluntarily recalling two (2) lots of Neostigmine Methylsulfate 5mL syringes to the user/hospital/clinic level. The specified product lots are being recalled because of a confirmed customer complaint that some syringe units containing Neostigmine Methylsulfate 1mg/mL, 5mg per 5mL are incorrectly labelled as Neostigmine Methylsulfate 1mg/mL, 3mg per 3mL. Secondary packages are properly labelled as Neostigmine Methylsulfate 1mg/mL, 5mg per 5mL.

FDA - U.S. Food and Drug Administration

There are no news related to this product.